Results 191 to 200 of about 11,900 (212)

Trends in Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Use in Burkina Faso, the Democratic Republic of Congo and Uganda

open access: yesContraception: X, 2019
Objectives Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is seen as a valuable innovation in family planning, but little is known about trends in DMPA-SC use or characteristics of users. Using data from Burkina Faso, the Democratic Republic of
Georges Guiella   +2 more
exaly   +2 more sources

Designing a Global Monitoring System for Pilot Introduction of a New Contraceptive Technology, Subcutaneous DMPA (DMPA-SC)

open access: yesEvaluation and Program Planning, 2018
Highlights • From 2014 to 2016, the MOHs of Burkina Faso, Niger, Senegal and Uganda launched pilot introductions of the novel injectable contraceptive DMPA-SC.• This manuscript describes a four-phase approach to monitoring DMPA-SC pilot introduction ...
Allen Namagembe
exaly   +2 more sources

Increased 1-year continuation of DMPA among women randomized to self-administration: results from a randomized controlled trial at Planned Parenthood.

Contraception, 2017
OBJECTIVES Self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-sc) is feasible, acceptable, and effective. Our objective was to compare one-year continuation of DMPA-sc between women randomized to self-administration versus clinic
J. Kohn   +8 more
semanticscholar   +1 more source

Contraceptive Efficacy and Safety of DMPA-SC

Contraception, 2004
A M Kaunitz, A M Kaunitz
exaly  

Effects of DMPA on Weight and Blood Pressure in Long Term Acceptors

Contraception, 1999
Unnop Jaisamrarn   +2 more
exaly  

Factors Affecting Continuation Rates of DMPA

Contraception, 1999
Doug Taylor, D Hubacher
exaly  

Home - About - Disclaimer - Privacy